HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Cirino Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2010Exercise capacity and cytochrome oxidase activity in muscle mitochondria of COPD patients.
12/2005A protective role for proteinase activated receptor 2 in airways of lipopolysaccharide-treated rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Cirino Research Topics

Disease

27Inflammation (Inflammations)
12/2023 - 12/2002
12Neoplasms (Cancer)
04/2023 - 02/2006
12Asthma (Bronchial Asthma)
01/2023 - 12/2005
11Melanoma (Melanoma, Malignant)
01/2020 - 06/2005
7Edema (Dropsy)
12/2023 - 01/2005
7Erectile Dysfunction
10/2017 - 12/2009
5Rheumatoid Arthritis
11/2023 - 12/2004
4Respiratory Hypersensitivity
12/2022 - 06/2007
4Hypertension (High Blood Pressure)
01/2020 - 04/2014
3Arthritis (Polyarthritis)
11/2023 - 12/2004
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2023 - 11/2004
3Malignant Hyperthermia
01/2022 - 01/2016
3Fibrosis (Cirrhosis)
08/2021 - 02/2004
3Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 11/2016
3Pneumonia (Pneumonitis)
01/2019 - 10/2015
3Colitis
01/2018 - 12/2002
3Vascular Diseases (Vascular Disease)
11/2017 - 01/2002
2Non-alcoholic Fatty Liver Disease
12/2023 - 12/2023
2Body Weight (Weight, Body)
12/2023 - 09/2004
2Alzheimer Disease (Alzheimer's Disease)
01/2023 - 05/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2016 - 08/2008
2Ischemia
11/2016 - 01/2016
2Reperfusion Injury
11/2016 - 01/2016
2Chronic Obstructive Pulmonary Disease (COPD)
01/2010 - 12/2005
2Pigmented Nevus (Melanocytic Nevus)
02/2006 - 06/2005
2Glycosuria
11/2005 - 04/2004
1Dysbiosis
12/2023
1Fatty Liver
12/2023
1Hypotension (Low Blood Pressure)
12/2023
1Atherosclerosis
12/2023
1Insulin Resistance
12/2023
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2023
1Triple Negative Breast Neoplasms
04/2023
1Airway Remodeling
01/2023

Drug/Important Bio-Agent (IBA)

27Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2023 - 01/2006
7CarrageenanIBA
12/2023 - 01/2005
7Cysteine (L-Cysteine)FDA Link
11/2023 - 04/2011
7Proteins (Proteins, Gene)FDA Link
11/2018 - 12/2004
6sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022 - 05/2010
5CystathionineIBA
11/2023 - 10/2014
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2023 - 01/2005
5AllergensIBA
01/2022 - 05/2013
4EnzymesIBA
11/2023 - 11/2006
4GasotransmittersIBA
01/2020 - 10/2014
4Celecoxib (Celebrex)FDA Link
01/2017 - 12/2004
4Phosphodiesterase 5 InhibitorsIBA
01/2016 - 12/2009
3LigandsIBA
12/2023 - 02/2006
3CytokinesIBA
11/2023 - 11/2006
3isothiocyanic acidIBA
04/2023 - 11/2016
3Phosphates (Orthophosphate)IBA
01/2022 - 06/2007
3SphingosineIBA
01/2022 - 06/2007
3sphingosine kinaseIBA
01/2020 - 06/2007
3Naproxen (Naprosyn)FDA LinkGeneric
01/2019 - 12/2004
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2018 - 01/2016
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2016 - 12/2004
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2016 - 04/2006
3zofenoprilIBA
01/2016 - 08/2008
3sodium bisulfide (NaHS)IBA
10/2014 - 01/2006
3Clarithromycin (Biaxin)FDA LinkGeneric
11/2013 - 11/2007
3ThrombinFDA Link
07/2010 - 11/2004
3Messenger RNA (mRNA)IBA
10/2006 - 12/2004
3Peptide Hydrolases (Proteases)FDA Link
07/2006 - 11/2004
2ApolipoproteinsIBA
12/2023 - 12/2023
2SphingolipidsIBA
11/2023 - 05/2010
2Interleukin-17 (Interleukin 17)IBA
11/2023 - 01/2023
2Sphingosine-1-Phosphate ReceptorsIBA
11/2023 - 08/2021
2Nitric Oxide Synthase (NO Synthase)IBA
11/2023 - 01/2005
2Formoterol Fumarate (Oxis)FDA Link
12/2022 - 02/2013
2Adrenergic Receptors (Adrenergic Receptor)IBA
07/2022 - 10/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
05/2022 - 04/2015
2PAR-2 ReceptorIBA
11/2017 - 01/2002
2Biomarkers (Surrogate Marker)IBA
01/2017 - 12/2009
22-(6-methoxy-napthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl esterIBA
12/2016 - 03/2010
2GlucocorticoidsIBA
04/2015 - 10/2014
2LyasesIBA
01/2015 - 10/2014
2Diclofenac (SR 38)FDA LinkGeneric
01/2007 - 10/2006
2Adenosine Triphosphate (ATP)IBA
10/2006 - 10/2006
2Acetylcholine (Acetylcholine Chloride)FDA Link
11/2005 - 04/2004
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2005 - 02/2003
1GTP-Binding Proteins (G-Protein)IBA
12/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2023
1CholesterolIBA
12/2023
1BAR502IBA
12/2023
1Bile Acids and Salts (Bile Acids)IBA
12/2023
1Atorvastatin (Lipitor)FDA Link
12/2023
1Apolipoproteins E (ApoE)IBA
12/2023
16-ethyl-3,7-dihydroxycholan-24-olIBA
12/2023
1FructoseIBA
12/2023
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2023
1InterleukinsIBA
11/2023
1Immunomodulating AgentsIBA
11/2023
1erucinIBA
04/2023
1Prednisone (Sone)FDA LinkGeneric
01/2023
1Amyloid (Amyloid Fibrils)IBA
01/2023

Therapy/Procedure

9Therapeutics
12/2022 - 08/2008
3Oral Administration
01/2022 - 09/2004
2Immunotherapy
01/2020 - 01/2017
2Chemoprevention
01/2019 - 01/2016
1Drug Therapy (Chemotherapy)
04/2023